CCL2 and autoimmune thyroid disease: A cross-sectional study reported that systemic inflammation increases with visceral obesity and insulin resistance, with monocyte chemoattractant protein-1 (MCP-1) levels correlating with both the homeostatic model assessment of insulin resistance (HOMA-IR) and antithyroperoxidase antibodies (ATPO), indicating a potential link between metabolic inflammation and autoimmune thyroiditis [179].